Radioterapia Estereotáctica Corporal (SBRT)

Indicaciones en patologías según el sitio anatómico a tratar:

1- Raquimedular 49-51

La radioterapia estereotáctica corporal (SBRT) usa altas dosis ablativas de irradiación en pocas

fracciones sobre tumores raquimedulares a los fines terapéuticos y para controlar síntomas.

Metástasis Vertebral

2- Pulmón 52-55 56-59

En tumores localmente avanzados, es decir no son operables, la SBRT es una opción de tratamiento

con resultados favorables y baja toxicidad.

Cáncer de Pulmón Inoperable

3- Hígado 60-62 63-68

En pacientes con metástasis hepáticas o tumores primarios, la SBRT ha demostrado excelente control

local con erradicación de la enfermedad visible.

PET-RM metástasis hepática SBRT metástasis hepática

4- Páncreas 69-71

La radioterapia estereotáctica corporal (SBRT) usa altas dosis ablativas de irradiación en pocas

fracciones sobre tumores pancreáticos inoperables, con buen control local y mejoría de la clínica.

SBRT en Cáncer de Páncreas

5- Próstata 72-74

En pacientes selectos, la SBRT de próstata durante 1 semana, tiene similares resultados que

los tratamientos convencionales de 8 semanas, lo que brinda confort al paciente.

SBRT en Cáncer de Próstata (5 días de tratamiento)

6- Oligometástasis 75-77

Un nuevo concepto de tratamiento es el tratamiento de varios focos de enfermedad visible, conocido

como oligometástasis, que es factible de ser irradiado puntualmente protegiendo tejido sano próximo. De esta

forma no sólo controlaríamos la enfermedad visible, sino que colaboraría a que continúen los tratamientos

sistémicos en el resto del cuerpo.

PET-RM metástasis ganglionar SBRT metástasis ganglionar

7- Re-Irradiación 78-80 En casos donde la enfermedad es recidiva y no es factible una cirugía oncológica, la re-irradiación

con altas dosis y precisión ha demostrado eficacia en el control local con buena tolerancia.

SBRT en recidiva de Cáncer de Cabeza y Cuello

Bibliografía

1. Timmerman R, Bastasch M, Saha D, et al: Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 40:352-65, 2007 2. Benedict SH, Yenice KM, Followill D, et al: Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078-101, 2010 3. Timmerman RD, Kavanagh BD, Cho LC, et al: Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25:947-52, 2007 4. Wolf A, Kondziolka D: Brain metastases: radiosurgery. Handb Clin Neurol 149:129-135, 2018 5. Soike MH, Hughes RT, Farris M, et al: Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases? Neurosurgery, 2018 6. Qie S, Li Y, Shi HY, et al: Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials. Medicine (Baltimore) 97:e11777, 2018 7. Llopez Carratala I, Escorihuela Garcia V, Orts Alborch M, et al: Radiosurgery as treatment for acoustic neuroma. Ten years' experience. Acta Otorrinolaringol Esp 65:327-31, 2014 8. Flickinger JC, Kondziolka D, Niranjan A, et al: Results of acoustic neuroma radiosurgery: an analysis of 5 years' experience using current methods. J Neurosurg 119 Suppl:1-6, 2013 9. Roos DE, Potter AE, Brophy BP: Stereotactic radiosurgery for acoustic neuromas: what happens long term? Int J Radiat Oncol Biol Phys 82:1352-5, 2012 10. Wang WH, Lee CC, Yang HC, et al: Gamma Knife Radiosurgery for Atypical and Anaplastic Meningiomas. World Neurosurg 87:557-64, 2016 11. Sheehan JP, Starke RM, Kano H, et al: Gamma Knife radiosurgery for posterior fossa meningiomas: a multicenter study. J Neurosurg 122:1479-89, 2015 12. Sethi RA, Rush SC, Liu S, et al: Dose-Response Relationships for Meningioma Radiosurgery. Am J Clin Oncol 38:600-4, 2015 13. Xu KM, Quan K, Clump DA, et al: Stereotactic ablative radiosurgery for locally advanced or recurrent skull base malignancies with prior external beam radiation therapy. Front Oncol 5:65, 2015 14. Cohen-Inbar O, Lee CC, Schlesinger D, et al: Long-Term Results of Stereotactic Radiosurgery for Skull Base Meningiomas. Neurosurgery, 2015 15. Vera E, Iorgulescu JB, Raper DM, et al: A review of stereotactic radiosurgery practice in the management of skull base meningiomas. J Neurol Surg B Skull Base 75:152-8, 2014 16. Umansky D, Corn BW, Strauss I, et al: Combined treatment approach to cerebral arteriovenous malformation in pediatric patients: stereotactic radiosurgery to partially Onyx-embolized AVM. Childs Nerv Syst, 2018 17. Back AG, Zeck O, Shkedy C, et al: Staged embolization with staged gamma knife radiosurgery to treat a large AVM. Can J Neurol Sci 36:500-3, 2009 18. Stevens MTR, Lobb EC, Yenice KM: Validation of MLC-based linac radiosurgery for trigeminal neuralgia. J Appl Clin Med Phys 19:214-221, 2018 19. Taich ZJ, Goetsch SJ, Monaco E, et al: Stereotactic Radiosurgery Treatment of Trigeminal Neuralgia: Clinical Outcomes and Prognostic Factors. World Neurosurg 90:604-612 e11, 2016 20. Gianaris T, Witt T, Barbaro NM: Radiosurgery for Medial Temporal Lobe Epilepsy Resulting from Mesial Temporal Sclerosis. Neurosurg Clin N Am 27:79-82, 2016 21. Feng ES, Sui CB, Wang TX, et al: Stereotactic radiosurgery for the treatment of mesial temporal lobe epilepsy. Acta Neurol Scand, 2016 22. Raju SS, Niranjan A, Monaco EA, III, et al: Stereotactic Radiosurgery for Intractable Tremor-Dominant Parkinson Disease: A Retrospective Analysis. Stereotact Funct Neurosurg 95:291-297, 2017 23. Halvorsen PH, Cirino E, Das IJ, et al: AAPM-RSS Medical Physics Practice Guideline 9.a. for SRS-SBRT. J Appl Clin Med Phys 18:10-21, 2017 24. Teh BS, Paulino AC, Lu HH, et al: Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites. Technol Cancer Res Treat 6:347-54, 2007 25. Nakazawa H, Uchiyama Y, Komori M, et al: [Setup accuracy of stereotactic body radiation therapy (SBRT) using virtual isocenter in image-guided radiation therapy (IGRT)]. Nihon Hoshasen Gijutsu Gakkai Zasshi 68:1354-64, 2012 26. Caillet V, Booth JT, Keall P: IGRT and motion management during lung SBRT delivery. Phys Med 44:113-122, 2017 27. Kataria T, Gupta D, Karrthick KP, et al: Frame-based radiosurgery: Is it relevant in the era of IGRT? Neurol India 61:277-81, 2013 28. Hevezi JM: Current IGRT, SBRT, and SRS procedures and reimbursement. J Am Coll Radiol 7:739-40, 2010 29. Gerszten PC, Burton SA: Clinical assessment of stereotactic IGRT: spinal radiosurgery. Med Dosim 33:107-16, 2008 30. Takeuchi H, Yoshida M, Kubota T, et al: Frameless stereotactic radiosurgery with mobile CT, mask immobilization and micro-multileaf collimators. Minim Invasive Neurosurg 46:82-5, 2003 31. Chang HH, Lee HF, Sung CC, et al: A phantom study of the immobilization and the indications for using virtual isocenter in stereoscopic X-ray image guidance system referring to position localizer in frameless radiosurgery. J Appl Clin Med Phys

14:4133, 2013 32. Watanabe M, Onishi H, Kuriyama K, et al: Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors. J Radiat Res 54:762-8, 2013 33. Riou O, Llacer Moscardo C, Fenoglietto P, et al: SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques. Rep Pract Oncol Radiother 22:103-110, 2017 34. Ueda Y, Teshima T, Cardenes H, et al: Evaluation of initial setup errors of two immobilization devices for lung stereotactic body radiation therapy (SBRT). J Appl Clin Med Phys 18:62-68, 2017 35. Zheng D, Verma V, Wang S, et al: Does intensity modulation increase target dose calculation errors of conventional algorithms for lung SBRT? J Appl Clin Med Phys 19:154-159, 2018 36. Ong CCH, Ang KW, Soh RCX, et al: Dosimetric comparison of peripheral NSCLC SBRT using Acuros XB and AAA calculation algorithms. Med Dosim 42:216-222, 2017 37. Williams KM, Schulte RW, Schubert KE, et al: Evaluation of mathematical algorithms for automatic patient alignment in radiosurgery. Technol Cancer Res Treat 14:326-33, 2015 38. Sini C, Broggi S, Fiorino C, et al: Accuracy of dose calculation algorithms for static and rotational IMRT of lung cancer: A phantom study. Phys Med 31:382-90, 2015 39. Lacornerie T, Lisbona A, Mirabel X, et al: GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms. Radiat Oncol 9:223, 2014 40. Fernandez MC, Venencia C, Garrigo E, et al: SU-E-T-454: Dosimetric Comparison between Pencil Beam and Monte Carlo Algorithms for SBRT Lung Treatment Using IPlan V4.1 TPS and CIRS Thorax Phantom. Med Phys 39:3809, 2012 41. Lax I, Panettieri V, Wennberg B, et al: Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol 45:978-88, 2006 42. Pallotta S, Calusi S, Foggi L, et al: ADAM: A breathing phantom for lung SBRT quality assurance. Phys Med 49:147-155, 2018 43. Bruschi A, Esposito M, Pini S, et al: How the detector resolution affects the clinical significance of SBRT pre-treatment quality assurance results. Phys Med 49:129-134, 2018 44. Kamerling CP, Fast MF, Ziegenhein P, et al: Online dose reconstruction for tracked volumetric arc therapy: Real-time implementation and offline quality assurance for prostate SBRT. Med Phys 44:5997-6007, 2017 45. Lo AC, Liu M, Chan E, et al: The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study. J Thorac Oncol 9:527-33, 2014 46. Faught AM, Kry SF, Luo D, et al: Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials. J Appl Clin Med Phys 14:4313, 2013 47. Dieterich S, Cavedon C, Chuang CF, et al: Report of AAPM TG 135: quality assurance for robotic radiosurgery. Med Phys 38:2914-36, 2011 48. Ramaseshan R, Heydarian M: Comprehensive quality assurance for stereotactic radiosurgery treatments. Phys Med Biol 48:N199-205, 2003 49. Redmond KJ, Lo SS, Fisher C, et al: Postoperative Stereotactic Body Radiation Therapy (SBRT) for Spine Metastases: A Critical Review to Guide Practice. Int J Radiat Oncol Biol Phys 95:1414-1428, 2016 50. Ryu S, Pugh SL, Gerszten PC, et al: RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol 4:76-81, 2014 51. Guckenberger M, Sweeney RA, Flickinger JC, et al: Clinical practice of image-guided spine radiosurgery--results from an international research consortium. Radiat Oncol 6:172, 2011 52. von Reibnitz D, Shaikh F, Wu AJ, et al: Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). Acta Oncol:1-7, 2018 53. Shioyama Y, Onishi H, Takayama K, et al: Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database. Technol Cancer Res Treat 17:1533033818783904, 2018 54. Shinde A, Li R, Kim J, et al: Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol, 2018 55. Rusthoven CG, Jones BL, Kavanagh BD: Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer. J Thorac Cardiovasc Surg 155:810-811, 2018 56. Patel KR, Prabhu RS, Kandula S, et al: Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. J Neurooncol 120:657-63, 2014 57. Serrano-Rubio AA, Martinez-Manrique JJ, Revuelta-Gutierrez R, et al: [Linear accelerator-based stereotactic radiosurgery for the treatment of trigeminal neuralgia. Nine years' experience in a single institution]. Rev Neurol 59:249-54, 2014 58. Yang TJ, Oh JH, Folkert MR, et al: Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 90:518-25, 2014 59. Tuchman A, Yu C, Chang EL, et al: Radiosurgery for metastatic disease at the craniocervical junction. World Neurosurg 82:1331-6, 2014 60. Miften M, Vinogradskiy Y, Moiseenko V, et al: Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys, 2018 61. Mahadevan A, Blanck O, Lanciano R, et al: Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch(R) Patient Registry. Radiat Oncol 13:26, 2018 62. Scorsetti M, Franceschini D, De Rose F, et al: The role of SBRT in oligometastatic patients with liver metastases from breast cancer. Rep Pract Oncol Radiother 22:163-169, 2017 63. Dawson LA, Eccles C, Craig T: Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45:856-64, 2006

64. De Bari B, Guillet M, Mornex F: [Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art]. Cancer Radiother 15:72-6, 2011 65. de Pooter JA, Mendez Romero A, Wunderink W, et al: Automated non-coplanar beam direction optimization improves IMRT in SBRT of liver metastasis. Radiother Oncol 88:376-81, 2008 66. Ibarra RA, Rojas D, Snyder L, et al: Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol, 2012 67. Kavanagh BD, Schefter TE, Cardenes HR, et al: Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45:848-55, 2006 68. Schefter TE, Kavanagh BD, Timmerman RD, et al: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371-8, 2005 69. Lischalk JW, Burke A, Chew J, et al: Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer. J Gastrointest Cancer 49:116-123, 2018 70. Ng SP, Herman JM: SBRT for Unresectable Pancreatic Cancer Can Improve Local Control With Minimal Toxicity. Int J Radiat Oncol Biol Phys 99:298-299, 2017 71. Groot VP, van Santvoort HC, Rombouts SJ, et al: Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT. HPB (Oxford) 19:83-92, 2017 72. Loblaw A, Liu S, Cheung P: Stereotactic ablative body radiotherapy in patients with prostate cancer. Transl Androl Urol 7:330-340, 2018 73. Li W, Lu L, Stephans KL, et al: Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancer. J Appl Clin Med Phys 19:198-203, 2018 74. Kothari G, Loblaw A, Tree AC, et al: Stereotactic Body Radiotherapy for Primary Prostate Cancer. Technol Cancer Res Treat 17:1533033818789633, 2018 75. Klement RJ, Hoerner-Rieber J, Adebahr S, et al: Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. Radiother Oncol 127:246-252, 2018 76. Andratschke N, Alheid H, Allgauer M, et al: The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer 18:283, 2018 77. Trager M, Salama J, Yin FF, et al: SBRT treatment of multiple extracranial oligometastases using a single isocenter with distinct optimizations. J Radiosurg SBRT 4:265-273, 2017 78. Vyfhuis MAL, Rice S, Remick J, et al: Reirradiation for locoregionally recurrent non-small cell lung cancer. J Thorac Dis 10:S2522-S2536, 2018 79. Vargo JA, Ward MC, Caudell JJ, et al: A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. Int J Radiat Oncol Biol Phys 100:595-605, 2018 80. Dagoglu N, Callery M, Moser J, et al: Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer. J Cancer 7:283-8, 2016 81. Chang Z, Wang Z, Ma J, et al: 6D image guidance for spinal non-invasive stereotactic body radiation therapy: Comparison between ExacTrac X-ray 6D with kilo-voltage cone-beam CT. Radiother Oncol 95:116-21, 2010 82. Delpon G, Llagostera C, Le Blanc M, et al: [Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy)]. Cancer Radiother 13:399-407, 2009 83. Ram TS, Badkul R, Maraboyina S, et al: A comparative study to evaluate the efficacy of on board imaging with cone beam CT using target registration in patients with lung tumors undergoing stereotactic body radiation therapy and comparison with ExacTrac using skeletal registration on Novalis Tx. J Cancer Res Ther 7:304-7, 2011